Definition:
The General & Plastic Surgery Devices market represents medical devices designed for general and plastic surgery procedures, such as disposable surgical supplies, open surgery instruments, minimally invasive surgery instruments.
Additional information:
Market values represent revenues paid to primary vendors at manufacturer price level either directly or through distribution channels (excluding VAT). Reported market revenues include spending by consumers (B2C), enterprises (B2B) as well as governments (B2G). Revenues are allocated to the country where the money is spent.
Company examples: Medtronic, Johnson & Johnson, Becton Dickinson, Conmed Corporation. Further information on the key players can be found in the Market Shares boxes.
Notes: Data shown is using current exchange rates and reflects market impacts of the Russia-Ukraine war.
Most recent update: Aug 2024
Source: Statista Market Insights
Notes: The chart “Comparable Estimates” shows the forecasted development of the selected market from different sources. Please see the additional information for methodology and publication date.
Most recent update: Mar 2024
Most recent update: Mar 2024
Source: Statista Market Insights
The General & Plastic Surgery Devices market in Ireland is experiencing steady growth due to increasing customer preferences for cosmetic and reconstructive procedures, as well as advancements in technology and the availability of specialized healthcare facilities. Customer preferences in Ireland are shifting towards a greater acceptance and demand for cosmetic and reconstructive surgeries. This is driven by factors such as changing societal norms, increased awareness about the benefits of these procedures, and a desire for self-improvement. As a result, there is a growing demand for general and plastic surgery devices in the country. Trends in the market indicate a strong focus on technological advancements and innovation. Manufacturers are constantly developing new and improved devices to meet the evolving needs of healthcare professionals and patients. This includes the development of minimally invasive procedures, robotic-assisted surgeries, and advanced imaging technologies. These advancements not only enhance the effectiveness and safety of procedures, but also contribute to shorter recovery times and improved patient outcomes. In addition to technological advancements, the availability of specialized healthcare facilities is driving the growth of the market. Ireland has a well-developed healthcare system with a number of specialized clinics and hospitals offering a wide range of general and plastic surgery procedures. This allows patients to access high-quality care close to home, reducing the need for international travel. Local special circumstances in Ireland also contribute to the growth of the General & Plastic Surgery Devices market. The country has a relatively high disposable income and a strong emphasis on personal appearance and grooming. This, combined with a growing aging population, has led to an increased demand for cosmetic procedures such as facelifts, breast augmentations, and liposuction. Underlying macroeconomic factors also play a role in the development of the market. Ireland has a stable economy with a favorable business environment, attracting both domestic and international investment. This has led to increased funding for research and development, as well as the establishment of new healthcare facilities. Additionally, the country's membership in the European Union provides access to a large market and regulatory harmonization, facilitating the import and export of medical devices. Overall, the General & Plastic Surgery Devices market in Ireland is experiencing growth due to customer preferences for cosmetic and reconstructive surgeries, advancements in technology, the availability of specialized healthcare facilities, local special circumstances, and underlying macroeconomic factors. The market is expected to continue growing as these factors continue to drive demand for general and plastic surgery devices in the country.
Most recent update: Aug 2024
Source: Statista Market Insights
Data coverage:
Data encompasses B2B, B2G, and B2C spend. Figures are based on medical devices and IVD revenues allocated to the country where the money is spent at manufacturer price levels excluding VAT.Modeling approach / Market size:
Modeling employs a top-down approach with a bottom-up validation, using financial information of the key players by market. Market sizes are determined by a top-down approach, based on a specific rationale for each market market and allocated to the covered countries according to the global market shares. As a basis for evaluating markets, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare system, and regulations concerning medical products. Next, we use further relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare payer system, and regulations concerning medical products. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators.Additional notes:
Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.Notes: Based on data from IMF, World Bank, UN and Eurostat
Most recent update: Sep 2024
Source: Statista Market Insights